Testing rollup Phenna readies private credit takeout

Share

News and Analysis

Testing rollup Phenna readies private credit takeout

Ryan Daniel's avatar
Laura Thompson's avatar
Karis Hustad's avatar
  1. Ryan Daniel
  2. +Laura Thompson
  3. + 1 more
4 min read

UK-based testing company Phenna Group has left investors feeling conflicted over its £845m-equivalent dual tranche TLB (euros and sterling) and delayed draw term loan (DDTL) deal. Lenders flagged concerns such as weak cash flow due to its acquisition-heavy past, and its UK concentration, but appreciated its strong market position and high recurring sales.

The new TLBs, alongside an equity injection of £130m, will refinance existing debt, finance pending acquisitions of £80m, deferred consideration payable of £26m (the partial cost of previous acquisitions) and transaction expenses.

The company’s existing private credit debt funded its buyout by Oakley Capital in 2022.

What are you waiting for?

Try it out
  • We're trusted by 9 of the top 10 Investment Banks

Cookies & Privacy

We would like to use cookies to improve our service. Is that ok?